These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26802016)

  • 41. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
    Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
    Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Menopausal hormone therapy and breast cancer risk.
    Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
    Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer susceptibility variants and mammographic density phenotypes in norwegian postmenopausal women.
    Ellingjord-Dale M; Grotmol T; Lee E; Van Den Berg DJ; Hofvind S; Couto E; Sovio U; Dos-Santos-Silva I; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1752-63. PubMed ID: 25002657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium.
    Blein S; Berndt S; Joshi AD; Campa D; Ziegler RG; Riboli E; Cox DG;
    Free Radic Res; 2014 Mar; 48(3):380-6. PubMed ID: 24437375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study.
    Cairat M; Fournier A; Murphy N; Biessy C; Scalbert A; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Arveux P; Boutron-Ruault MC; Cadeau C; Fortner RT; Kaaks R; Boeing H; Aleksandrova K; Peeters PHM; Van Gils CH; Wareham NJ; Khaw KT; Aune D; Riboli E; Gunter MJ; Dossus L
    Int J Cancer; 2018 Oct; 143(7):1688-1695. PubMed ID: 29707771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
    Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
    Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.
    Nickels S; Truong T; Hein R; Stevens K; Buck K; Behrens S; Eilber U; Schmidt M; Häberle L; Vrieling A; Gaudet M; Figueroa J; Schoof N; Spurdle AB; Rudolph A; Fasching PA; Hopper JL; Makalic E; Schmidt DF; Southey MC; Beckmann MW; Ekici AB; Fletcher O; Gibson L; Silva Idos S; Peto J; Humphreys MK; Wang J; Cordina-Duverger E; Menegaux F; Nordestgaard BG; Bojesen SE; Lanng C; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Brauch H; Brüning T; Harth V; ; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; ; Lambrechts D; Smeets D; Neven P; Paridaens R; Flesch-Janys D; Obi N; Wang-Gohrke S; Couch FJ; Olson JE; Vachon CM; Giles GG; Severi G; Baglietto L; Offit K; John EM; Miron A; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Chanock SJ; Lissowska J; Liu J; Cox A; Cramp H; Connley D; Balasubramanian S; Dunning AM; Shah M; Trentham-Dietz A; Newcomb P; Titus L; Egan K; Cahoon EK; Rajaraman P; Sigurdson AJ; Doody MM; Guénel P; Pharoah PD; Schmidt MK; Hall P; Easton DF; Garcia-Closas M; Milne RL; Chang-Claude J
    PLoS Genet; 2013; 9(3):e1003284. PubMed ID: 23544014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.
    Weng CH; Okawa ER; Roberts MB; Park SK; Umbricht CB; Manson JE; Eaton CB
    Thyroid; 2020 Apr; 30(4):519-530. PubMed ID: 31918623
    [No Abstract]   [Full Text] [Related]  

  • 53. Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.
    Cote DJ; Kilgallon JL; Nawabi NLA; Dawood HY; Smith TR; Kaiser UB; Laws ER; Manson JE; Stampfer MJ
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1402-e1412. PubMed ID: 34865056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
    Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
    Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Menopausal hormonal therapy and breast cancer.].
    Bakhidze EV; Belyaeva AV; Berlev IV; Anisimov VN; Belyaev AM
    Adv Gerontol; 2021; 34(2):277-286. PubMed ID: 34245512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
    Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
    Wang T; Bradshaw PT; Moorman PG; Nyante SJ; Nichols HB; Shantakumar S; Parada H; Khankari NK; Terry MB; Teitelbaum SL; Neugut AI; Gammon MD
    Int J Cancer; 2020 Dec; 147(12):3404-3415. PubMed ID: 32588422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
    Milne RL; Gaudet MM; Spurdle AB; Fasching PA; Couch FJ; Benítez J; Arias Pérez JI; Zamora MP; Malats N; Dos Santos Silva I; Gibson LJ; Fletcher O; Johnson N; Anton-Culver H; Ziogas A; Figueroa J; Brinton L; Sherman ME; Lissowska J; Hopper JL; Dite GS; Apicella C; Southey MC; Sigurdson AJ; Linet MS; Schonfeld SJ; Freedman DM; Mannermaa A; Kosma VM; Kataja V; Auvinen P; Andrulis IL; Glendon G; Knight JA; Weerasooriya N; Cox A; Reed MW; Cross SS; Dunning AM; Ahmed S; Shah M; Brauch H; Ko YD; Brüning T; ; Lambrechts D; Reumers J; Smeets A; Wang-Gohrke S; Hall P; Czene K; Liu J; Irwanto AK; Chenevix-Trench G; Holland H; ; ; Giles GG; Baglietto L; Severi G; Bojensen SE; Nordestgaard BG; Flyger H; John EM; West DW; Whittemore AS; Vachon C; Olson JE; Fredericksen Z; Kosel M; Hein R; Vrieling A; Flesch-Janys D; Heinz J; Beckmann MW; Heusinger K; Ekici AB; Haeberle L; Humphreys MK; Morrison J; Easton DF; Pharoah PD; García-Closas M; Goode EL; Chang-Claude J
    Breast Cancer Res; 2010; 12(6):R110. PubMed ID: 21194473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
    Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
    Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy.
    Rudolph A; Hein R; Hoffmeister M; Försti A; Hemminki K; Risch A; Brenner H; Chang-Claude J
    Int J Cancer; 2012 Sep; 131(5):E841-8. PubMed ID: 22234881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.